Latest Intelligence on Chemicals in North America

Published within

« | 1 | » »|

Type Product title / description Pub Price
CommentWire
CommentWire

E.ON: sacrifices needed for Powergen

Published By Datamonitor
22 Mar 2001
CommentWire
CommentWire

Akzo Nobel/Schering-Plough: good deal all round

Following months of speculation, the hybrid Dutch group Akzo Nobel has announced its decision to sell its healthcare business unit following a lucrative $14 billion cash offer from Schering-Plough. The US pharmaceutical company stands to gain access to one of the strongest women's health portfolios in the industry, and a CNS franchise that boasts a potential blockbuster in asenapine.

Published By Datamonitor
13 Mar 2007

« | 1 | » »|

No help is available.